Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (9)

2021

  1. Effectiveness of tianeptine in patients with m ajor depression and substance-related disorders

    Actas Espanolas de Psiquiatria, Vol. 49, Núm. 4, pp. 135-144

2020

  1. Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study (Drugs - Real World Outcomes, (2020), 7, 1, (75-83), 10.1007/s40801-020-00178-8)

    Drugs - Real World Outcomes

  2. Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

    Drugs - Real World Outcomes, Vol. 7, Núm. 1, pp. 75-83

2019

  1. Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology

    Actas Espanolas de Psiquiatria, Vol. 47, Núm. 5, pp. 218-228

2017

  1. Madrid Study (Spain) on the Prevalence and Characteristics of Outpatients with Dual Disorders

    Addictive Disorders and their Treatment, Vol. 16, Núm. 4, pp. 187-200

2013

  1. Abuse or dependence on cannabis and other psychiatric disorders. Madrid study on dual pathology prevalence

    Actas Espanolas de Psiquiatria, Vol. 41, Núm. 2, pp. 122-129

  2. Abuso o dependencia a la cocaína y otros trastornos psiquiátricos. Estudio Madrid sobre la prevalencia de la patología dual

    Revista de Psiquiatria y Salud Mental, Vol. 6, Núm. 3, pp. 121-128

  3. Alcohol abuse or dependence and other psychiatric disorders. Madrid study on the prevalence of dual pathology

    Mental Health and Substance Use: Dual Diagnosis, Vol. 6, Núm. 4, pp. 339-350

2006

  1. Efectividad y tolerancia de la adición de risperidona en el trastorno obsesivo-compulsivo con mala respuesta terapéutica a inhibidores de la recaptación de serotonina

    Actas Espanolas de Psiquiatria, Vol. 34, Núm. 3, pp. 147-152